Topic
Post-Grant Proceedings
130 published works
PTAB Litigation Blog
PGR Petitions Are “Favored”
Visit Jones Day's PTAB Litigation blog at www.ptablitigationblog.com. By Elizabeth Schrieber and Matt Johnson – In Multi-Color Corp. v. Brook & Whittle Ltd., PGR2025-00025, the PTAB declined to discretionarily deny…
IP Law Watch
PTAB Reenforces Preference for PGR
By Connie Jaw
The Patent Trial and Appeal Board (PTAB) recently designated a post-grant review (PGR) decision as precedential. In the decision, the Director issued a discretionary denial decision confirming that the proper…
Big Molecule Watch
Alvotech Files PGR Against Regeneron High-Dose Aflibercept Patent
On September 17, 2025, Alvotech USA Inc. and Alvotech hf. (“Alvotech”) filed a Petition for Post Grant Review of U.S. Patent No. 12,168,036 (“the ‘036 patent”), assigned to Regeneron Pharmaceuticals,…
PTAB Law Blog
USPTO Withdraws June 2022 Guidance on Fintiv Denials
On Friday, February 28, 2025, the United States Patent and Trademark Office (USPTO) announced the withdrawal of the June 2022 memorandum titled “Interim Procedure for Discretionary Denials in AIA Post-Grant…
PTAB Litigation Blog
PTAB Decides Concurrent IPR and PGR Petitions After Resolving Priority Date Dispute
By Lisa Furby
Visit Jones Day's PTAB Litigation blog at www.ptablitigationblog.com. By Lisa Furby and Anneli Kawaoka – In anticipating a dispute over whether the America Invents Act would apply, Petitioner MPL Brands…
Big Molecule Watch
Proposed USPTO Fee Changes Could Impact PGR and IPR Filing Strategies Used by Biosimilars
By Maria C. Smith|Sabrina Poulos
The USPTO has proposed several fee changes for implementation in 2025. If implemented, these changes will increase filing fees for Inter Partes Reviews (IPRs) and Post Grant Reviews (PGRs) by…
Life Science Legal Report
Real Parties-In-Interest: Guidance On Who Is An RPI-And Who Is Not-In Post-Grant Proceedings
By Emily J. Greb, Maria A. Stubbings
In a recent article, Real Parties In Interest Guidance On Who Is An RPI-And Who Is Not-In Post Grant Proceedings, linked here, Emily Greb and Maria Stubbing offer practical guidance and…
Global IP & Technology Law Blog
ITC Section 337: Tips for Avoiding Discretionary Denials at the PTAB
By Adam Hess
We previously wrote that a co-pending ITC Section 337 investigation virtually guarantees that the Patent Trial and Appeal Board (PTAB) will exercise its discretionary power to deny institution under 35…
Patents Post-Grant
PTAB Clarifies Director Rehearing Details
By Scott McKeown, Scott McKeown Wolf Greenfield
Arthrex Information Updated The USPTO requested feedback on the interim Director review process and, in response to that feedback, has updated the Arthrex Q&As. In response to questions from the public,…
Life Science Legal Report
PTAB Adds Online Public-Submission Forms
To guide and inform the public about the Patent Trial and Appeal Board's practice surrounding post-grant proceedings, the Board periodically designates certain of its decisions as precedential or informative. As…